We are live on ! Find out more
REUN

Reunion Neuroscience Inc. Common Shares

Delisted

REUN was delisted on the 31st of July, 2023.

27 hedge funds and large institutions have $2.15M invested in Reunion Neuroscience Inc. Common Shares in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% less funds holding

Funds holding: 3027 (-3)

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

69% less capital invested

Capital invested by funds: $6.88M → $2.15M (-$4.74M)

Holders
27
Holders Change
-3
Holders Change %
-10%
% of All Funds
0.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
3
Reduced
5
Closed
12
Calls
Puts
Net Calls
Net Calls Change

REUN Hedge Fund Activity: Q3 2022 in Review

27 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Reunion Neuroscience Inc. Common Shares (REUN) for Q3 2022, worth a combined $2.15M — down 69% from $6.88M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of REUN and 9 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 3 added.

The largest buyer was AdvisorShares Investments, adding an estimated $168K. The largest seller was DAFNA Capital Management, cutting an estimated $1.01M.

  • 27 institutional investors held Reunion Neuroscience Inc. Common Shares (REUN) as of Q3 2022, down from 30 in Q2 2022.
  • Funds reported $2.15M of Reunion Neuroscience Inc. Common Shares stock for Q3 2022, down 69% quarter-over-quarter.
  • 9 funds opened new Reunion Neuroscience Inc. Common Shares positions in Q3 2022 and 12 closed out, a net change of -3 holders.
  • The largest Reunion Neuroscience Inc. Common Shares buyer in Q3 2022 was AdvisorShares Investments, an estimated $168K added.
  • The largest Reunion Neuroscience Inc. Common Shares seller in Q3 2022 was DAFNA Capital Management, an estimated $1.01M sold.

Based on aggregated 13F filings for Q3 2022.